CBP 200 (Spectracef 200 mg)
Generic Name: cefditoren
Pill with imprint CBP 200 is White, Elliptical/Oval and has been identified as Spectracef 200 mg. It is supplied by Cornerstone BioPharma Inc.
Spectracef is used in the treatment of bronchitis; skin or soft tissue infection; tonsillitis/pharyngitis; pneumonia; skin and structure infection and belongs to the drug class third generation cephalosporins. There is no proven risk in humans during pregnancy. Spectracef 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CBP 200
Spectracef
- Generic Name
- cefditoren
- Imprint
- CBP 200
- Strength
- 200 mg
- Color
- White
- Size
- 17.00 mm
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Third generation cephalosporins
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cornerstone BioPharma Inc
- National Drug Code (NDC)
- 10122-0801 (Discontinued)
- Inactive Ingredients
-
carnauba wax,
croscarmellose sodium,
D&C Red No. 27,
mannitol,
hydroxypropyl cellulose,
hypromelloses,
magnesium stearate,
polyethylene glycol,
propylene glycol,
shellac,
sodium caseinate,
sodium tripolyphosphate,
titanium dioxide,
FD&C Blue No. 1
Note: Inactive ingredients may vary.
Related images for "CBP 200"
More about Spectracef (cefditoren)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (2)
- Drug images
- En español
- Drug class: third generation cephalosporins
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.